Teleconference Group: Breast Cancer in African Americans (STORY)

Completed · Not applicable

Conditions studied: Breast Cancer

In brief

African American women with breast cancer have decreased quality of life (and mood when compared to European American. Research has not examined the effectiveness of therapeutic group for African American women with breast cancer even though positive effects are well established for Caucasians. The aims of the randomized clinical trial are to determine the effectiveness of TG by teleconference for African American women with breast cancer and what factors may impact on the intervention. The primary hypothesis is that participants in the intervention group will have significantly greater cancer knowledge, less fear, less isolation, better social connection, better mood, and better QOL when compared to a control group receiving usual psychosocial care. Two hundred forty African American women with breast cancer will be recruited. Intervention participants attend eight weekly 90 minute sessions by teleconference and two follow-up boosters. Each culturally appropriate session contains the story, information and group processes of connection, commonality and catharsis. Information focuses on increasing self care and stress management knowledge while countering myths and taboos. Story capitalizes on African American oral traditions by discussing coping parables. Group processes provide an alternative source of social support and opportunities to express feelings. Control group subjects receive standard psychosocial care (the use of any support programs or services locally or nationally. Testing will occur at baseline, after 10 group sessions and 16 weeks post baseline. The study findings are expected to inform about the effectiveness of therapeutic groups in African American women with breast cancer and lay the groundwork for exploring if reducing disparities in psychosocial care have a health benefit.

Key facts

Study ID

NCT01339351

Run by

University of South Carolina

People needed

185

Starts

2005-06-01

Expected to finish

2010-08-01

Last updated by the study team

2019-04-18

Who can join

Age: 21 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• US born
• African American women
• age 21 or older
• diagnosed with invasive/infiltrating ductal carcinoma
• reside in South Carolina or the borders of North Carolina or Georgia

You may not qualify if…

• Non-english speaking
• diagnosed with metastatic disease at diagnosis
• have a major cognitive impairment
• have a current diagnosis of psychosis
• are undergoing concurrent treatment for another form of cancer (except basal cell or squamous cell of skin)
• Participation in another behavioral trial

Where it is running

• University of South Carolina — Columbia, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.